Day OneTuesday, 19 May 2026 - CET (Central European Time, GMT+01:00)

While Nordic countries lead in healthcare innovation and digital infrastructure, clinical AI adoption remains frustratingly slow despite countless successful pilots across the region's healthcare systems. This panel brings together innovators. digital leaders, and decision makers to share practical strategies for breaking through adoption barriers and building sustainable AI businesses.

• Breaking through the pilot-to-production barrier in healthcare systems

• Navigating Nordic procurement and reimbursement for AI solutions

• Generating real-world evidence that convinces healthcare administrators

The post-hype funding environment has fundamentally changed what makes a medtech startup investable, with investors now demanding robust business models and clear paths to profitability over flashy technology demos. This panel features active Nordic investors, successful founders to decode exactly what separates fundable medtech startups from the 90% that struggle to raise capital.

• Business model fundamentals that convince investors in today's market

• Regulatory pathway planning and de-risking for investors

• Common pitch deck mistakes that immediately disqualify startups

Reimbursement remains the ultimate make-or-break factor for medtech and digital health startups, with Nordic healthcare systems offering both unique opportunities through universal coverage and complex challenges through centralized decision-making. Our panel will discuss strategies for effective reimbursement in the Nordics with real-life case studies.

• Health Technology Assessment requirements across Nordic countries

• Building compelling health economics cases with limited real-world data

• Timing reimbursement applications with clinical evidence generation

EUMDR was designed for traditional medical devices, but AI and software-driven medtech are pushing regulatory frameworks to their breaking point with adaptive algorithms, continuous learning systems, and unprecedented innovation cycles. This panel brings together regulatory experts, AI medtech founders navigating MDR compliance, and investors to examine whether current regulations can handle the AI revolution, and what needs to change.

• Software a medical device and clinical decision support classifications

• Continuous learning algorithms and post-market surveillance under MDR

• Clinical evidence requirements for AI systems

• Harmonization challenges across EU member states for digital health

Unlock new possibilities for accessing the US public markets, and in particular, US Nasdaq. Join Mintz for a workshop exploring innovative routes beyond the conventional IPO. Gain valuable insights into alternative strategies to fuel your company's growth and expansion.

• Explore strategic alternatives to the traditional IPO process
• Learn how to navigate different pathways to the US public market
• Understand how these routes can help you achieve your financial objectives
• Gain valuable knowledge for your company's public market journey

The graveyard of failed medical devices is littered with brilliant technologies that never integrated into actual clinical workflows. While technical innovation captures headlines, the real success factor lies in understanding the human side of healthcare delivery, something only clinicians truly grasp. This panel features entrepreneurs, implementation experts, and investors to reveal why clinician involvement from day one isn't just helpful, it's essential for sustainable adoption.

• Designing tech for real-world healthcare delivery

• Building physician champions and overcoming clinical resistance

• User experience design for time-pressured healthcare environments

• Measuring implementation success beyond technical metrics

The Nordic medtech funding landscape differs drastically from Silicon Valley, with fewer mega-funds, longer decision cycles, and unique regional dynamics. But this creates opportunities for alternative funding strategies that many founders overlook. This panel explores the reality of raising capital in the Nordics, from government grants and corporate partnerships to revenue-based financing and strategic investors, revealing how successful founders have navigated limited local VC pools while building sustainable businesses.

• Fund sizes, investment criteria, and decision timelines of Nordic VCs

• Utilising government funding ecosystems

• The mindset shift of Nordic CEOs, becoming more entrepreneurial

• Alternative funding sources, including venture debt and crowdfunding